Epstein Andrew J, de Castro Terla N, Laibson Peter R, Cohen Elisabeth J, Rapuano Christopher J
Cornea Service, Wills Eye Hospital, Jefferson Medical College of Thomas Jefferson University, Philadelphia, PA 19107, USA.
Cornea. 2006 Oct;25(9):1005-11. doi: 10.1097/01.ico.0000240098.01468.4c.
To evaluate the relationship between topical corticosteroids and other variables and the risk for rejection after penetrating keratoplasty for keratoconus.
The records of all keratoconus patients who, after their first penetrating keratoplasty in that eye, experienced a first episode of corneal graft rejection during a specific 3-year period were retrospectively reviewed in a case-control fashion. Twenty-three cases were identified, and they were matched with 3 controls each, for a total of 69 controls and 92 total patients. Multiple variables including steroid potency, recent steroid tapering, and length of time on the current level of steroids were analyzed to see whether there were any significant relationships between postoperative changes in steroid management and rejection. In addition, other variables such as graft size, suture technique, recent suture removal, suture status at the time of the rejection episode, and prior grafting in the fellow eye were examined to determine if any of these factors were associated with a higher risk of graft rejection.
Most of the proposed risk factors, including steroid dose and tapering, differing suturing techniques, loose and/or broken sutures at the time of rejection, percentage of sutures remaining at the time of rejection, and prior grafting in the fellow eye, did not correlate with the risk of rejection. Only graft size had a correlation, with host trephination size > or = 8.25 mm having a nearly sixfold increased risk of rejection (P = 0.015). Most patients (70%) were diagnosed with rejection at a scheduled office visit rather than at an emergency visit, and correspondingly, nearly one half (43%) had no symptoms when rejection was identified. There was no significant difference in final best-corrected visual acuities between the cases and controls, and 91% of the corneas that underwent rejection did not progress to graft failure, remaining centrally clear at most recent follow-up.
In this study, the most important risk factor for rejection after corneal transplantation for keratoconus was the size of the graft. Physician detection of rejection is paramount, because a graft rejection episode is more often diagnosed at a scheduled office visit than at an emergency visit. Fortunately, progression to graft failure can usually be prevented if treatment is started promptly and intensively.
评估局部用皮质类固醇及其他变量与圆锥角膜穿透性角膜移植术后排斥反应风险之间的关系。
采用病例对照研究方法,对所有圆锥角膜患者在该眼首次穿透性角膜移植术后特定3年期间发生首次角膜移植排斥反应的记录进行回顾性分析。共确定了23例病例,并为每例病例匹配3名对照,对照组共69例,患者总数为92例。分析了多个变量,包括类固醇效力、近期类固醇减量情况以及当前类固醇水平的使用时长,以观察类固醇管理的术后变化与排斥反应之间是否存在显著关系。此外,还检查了其他变量,如移植片大小、缝合技术、近期缝线拆除情况、排斥反应发作时的缝线状态以及对侧眼先前的移植情况,以确定这些因素是否与移植排斥反应的较高风险相关。
大多数提出的风险因素,包括类固醇剂量和减量、不同的缝合技术、排斥反应时缝线松动和/或断裂、排斥反应时剩余缝线的百分比以及对侧眼先前的移植情况,均与排斥反应风险无关。只有移植片大小存在相关性,供体植床大小≥8.25 mm时排斥反应风险增加近6倍(P = 0.015)。大多数患者(70%)在定期门诊就诊时被诊断为排斥反应,而非急诊就诊时,相应地,近一半(43%)患者在确诊排斥反应时无症状。病例组和对照组最终最佳矫正视力无显著差异,91%发生排斥反应的角膜未进展至移植失败,在最近一次随访时中央仍保持清晰。
在本研究中,圆锥角膜角膜移植术后排斥反应的最重要风险因素是移植片大小。医生对排斥反应的检测至关重要,因为移植排斥反应更常发生在定期门诊就诊时,而非急诊就诊时。幸运的是,如果及时且积极地开始治疗,通常可以预防进展至移植失败。